Subscribe To Our Free Newsletter |
Concord Biotech lists at 21% premium over its issue price
The shares of the biopharma company listed at Rs 900, a 21 per cent higher against its issue price of Rs 741 per share on the National Stock Exchange and BSE on Friday.